179033-51-3 Usage
Uses
Used in Oncology:
TiMcodar is used as a P-glycoprotein inhibitor for enhancing the effectiveness of chemotherapy drugs in treating multidrug-resistant cancers. By preventing the removal of anticancer drugs from cancer cells, TiMcodar helps overcome drug resistance and improve therapeutic outcomes.
Used in Drug Resistance Management:
TiMcodar is used as a therapeutic agent for managing drug resistance in cancer treatment. Its ability to inhibit P-glycoprotein makes it a promising candidate for improving the efficacy of chemotherapy in resistant cases, thereby increasing the chances of successful cancer treatment.
Used in Combination Therapy:
TiMcodar is used as an adjunct to other chemotherapy medications for combination therapy in cancer treatment. Its good safety profile and tolerability when used in combination with other drugs make it a valuable component in multidrug treatment regimens, potentially leading to better patient outcomes and improved cancer management.
Check Digit Verification of cas no
The CAS Registry Mumber 179033-51-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,9,0,3 and 3 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 179033-51:
(8*1)+(7*7)+(6*9)+(5*0)+(4*3)+(3*3)+(2*5)+(1*1)=143
143 % 10 = 3
So 179033-51-3 is a valid CAS Registry Number.
179033-51-3Relevant articles and documents
Amino acid derivatives with improved multi-drug resistance activity
-
, (2008/06/13)
The present invention relates to compounds that can maintain, increase, or restore sensitivity of cells to therapeutic or prophylactic agents. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmac